These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 8872460)
1. New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome. Engel AG; Ohno K; Milone M; Wang HL; Nakano S; Bouzat C; Pruitt JN; Hutchinson DO; Brengman JM; Bren N; Sieb JP; Sine SM Hum Mol Genet; 1996 Sep; 5(9):1217-27. PubMed ID: 8872460 [TBL] [Abstract][Full Text] [Related]
2. Slow-channel myasthenic syndrome caused by enhanced activation, desensitization, and agonist binding affinity attributable to mutation in the M2 domain of the acetylcholine receptor alpha subunit. Milone M; Wang HL; Ohno K; Fukudome T; Pruitt JN; Bren N; Sine SM; Engel AG J Neurosci; 1997 Aug; 17(15):5651-65. PubMed ID: 9221765 [TBL] [Abstract][Full Text] [Related]
3. Congenital myasthenic syndromes due to heteroallelic nonsense/missense mutations in the acetylcholine receptor epsilon subunit gene: identification and functional characterization of six new mutations. Ohno K; Quiram PA; Milone M; Wang HL; Harper MC; Pruitt JN; Brengman JM; Pao L; Fischbeck KH; Crawford TO; Sine SM; Engel AG Hum Mol Genet; 1997 May; 6(5):753-66. PubMed ID: 9158150 [TBL] [Abstract][Full Text] [Related]
4. Mutations in different functional domains of the human muscle acetylcholine receptor alpha subunit in patients with the slow-channel congenital myasthenic syndrome. Croxen R; Newland C; Beeson D; Oosterhuis H; Chauplannaz G; Vincent A; Newsom-Davis J Hum Mol Genet; 1997 May; 6(5):767-74. PubMed ID: 9158151 [TBL] [Abstract][Full Text] [Related]
5. Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel openings due to a mutation in the M2 domain of the epsilon subunit. Ohno K; Hutchinson DO; Milone M; Brengman JM; Bouzat C; Sine SM; Engel AG Proc Natl Acad Sci U S A; 1995 Jan; 92(3):758-62. PubMed ID: 7531341 [TBL] [Abstract][Full Text] [Related]
6. Modulation of the Ca(2+) permeability of human endplate acetylcholine receptor-channel. Piccari V; Deflorio C; Bigi R; Grassi F; Fucile S Cell Calcium; 2011 Apr; 49(4):272-8. PubMed ID: 21470676 [TBL] [Abstract][Full Text] [Related]
7. End-plate acetylcholine receptor deficiency due to nonsense mutations in the epsilon subunit. Engel AG; Ohno K; Bouzat C; Sine SM; Griggs RC Ann Neurol; 1996 Nov; 40(5):810-7. PubMed ID: 8957026 [TBL] [Abstract][Full Text] [Related]
8. Congenital myasthenic syndrome caused by decreased agonist binding affinity due to a mutation in the acetylcholine receptor epsilon subunit. Ohno K; Wang HL; Milone M; Bren N; Brengman JM; Nakano S; Quiram P; Pruitt JN; Sine SM; Engel AG Neuron; 1996 Jul; 17(1):157-70. PubMed ID: 8755487 [TBL] [Abstract][Full Text] [Related]
9. Congenital myasthenic syndrome caused by low-expressor fast-channel AChR delta subunit mutation. Shen XM; Ohno K; Fukudome T; Tsujino A; Brengman JM; De Vivo DC; Packer RJ; Engel AG Neurology; 2002 Dec; 59(12):1881-8. PubMed ID: 12499478 [TBL] [Abstract][Full Text] [Related]
10. Subunit-specific contribution to agonist binding and channel gating revealed by inherited mutation in muscle acetylcholine receptor M3-M4 linker. Shen XM; Ohno K; Sine SM; Engel AG Brain; 2005 Feb; 128(Pt 2):345-55. PubMed ID: 15615813 [TBL] [Abstract][Full Text] [Related]
11. Mutation of the acetylcholine receptor alpha subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinity. Sine SM; Ohno K; Bouzat C; Auerbach A; Milone M; Pruitt JN; Engel AG Neuron; 1995 Jul; 15(1):229-39. PubMed ID: 7619526 [TBL] [Abstract][Full Text] [Related]
12. End-plate gamma- and epsilon-subunit mRNA levels in AChR deficiency syndrome due to epsilon-subunit null mutations. Croxen R; Young C; Slater C; Haslam S; Brydson M; Vincent A; Beeson D Brain; 2001 Jul; 124(Pt 7):1362-72. PubMed ID: 11408331 [TBL] [Abstract][Full Text] [Related]
13. Mutation of the acetylcholine receptor epsilon-subunit promoter in congenital myasthenic syndrome. Nichols P; Croxen R; Vincent A; Rutter R; Hutchinson M; Newsom-Davis J; Beeson D Ann Neurol; 1999 Apr; 45(4):439-43. PubMed ID: 10211467 [TBL] [Abstract][Full Text] [Related]
14. Congenital myasthenic syndromes: recent advances. Engel AG; Ohno K; Sine SM Arch Neurol; 1999 Feb; 56(2):163-7. PubMed ID: 10025421 [TBL] [Abstract][Full Text] [Related]
15. Mutation in the M1 domain of the acetylcholine receptor alpha subunit decreases the rate of agonist dissociation. Wang HL; Auerbach A; Bren N; Ohno K; Engel AG; Sine SM J Gen Physiol; 1997 Jun; 109(6):757-66. PubMed ID: 9222901 [TBL] [Abstract][Full Text] [Related]
16. A leucine-to-phenylalanine substitution in the acetylcholine receptor ion channel in a family with the slow-channel syndrome. Gomez CM; Gammack JT Neurology; 1995 May; 45(5):982-5. PubMed ID: 7538206 [TBL] [Abstract][Full Text] [Related]
17. Acetylcholine receptor delta subunit mutations underlie a fast-channel myasthenic syndrome and arthrogryposis multiplex congenita. Brownlow S; Webster R; Croxen R; Brydson M; Neville B; Lin JP; Vincent A; Newsom-Davis J; Beeson D J Clin Invest; 2001 Jul; 108(1):125-30. PubMed ID: 11435464 [TBL] [Abstract][Full Text] [Related]
19. CHRND mutation causes a congenital myasthenic syndrome by impairing co-clustering of the acetylcholine receptor with rapsyn. Müller JS; Baumeister SK; Schara U; Cossins J; Krause S; von der Hagen M; Huebner A; Webster R; Beeson D; Lochmüller H; Abicht A Brain; 2006 Oct; 129(Pt 10):2784-93. PubMed ID: 16916845 [TBL] [Abstract][Full Text] [Related]
20. Slow-channel myasthenia due to novel mutation in M2 domain of AChR delta subunit. Shen XM; Milone M; Wang HL; Banwell B; Selcen D; Sine SM; Engel AG Ann Clin Transl Neurol; 2019 Oct; 6(10):2066-2078. PubMed ID: 31560172 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]